We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+3.18%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.36B
AUM Growth
+$200M
Cap. Flow
+$70.3M
Cap. Flow %
1.61%
Top 10 Hldgs %
17.48%
Holding
714
New
57
Increased
313
Reduced
227
Closed
46

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$27.6M
2
JNJ icon
Johnson & Johnson
JNJ
+$24.4M
3
ORCL icon
Oracle
ORCL
+$20.4M
4
MCHP icon
Microchip Technology
MCHP
+$17.1M
5
CPB icon
Campbell Soup
CPB
+$16.8M

Sector Composition

Rank Sector Weight
1 Healthcare 24.09%
2 Financials 14.65%
3 Technology 11.77%
4 Communication Services 9.13%
5 Consumer Staples 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLK icon
326
Blackrock
BLK
$164B
$2.34M 0.05%
6,148
-1,048
-15% -$384K
DTE icon
327
DTE Energy
DTE
$31.1B
$2.34M 0.05%
27,892
+2,089
+8% +$168K
ICPT
328
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.34M 0.05%
21,500
SWN
329
DELISTED
Southwestern Energy Company
SWN
$2.32M 0.05%
214,577
+62,547
+41% +$716K
SCHW
330
Charles Schwab
SCHW
$177B
$2.32M 0.05%
58,722
+7,590
+15% +$271K
PXD
331
DELISTED
Pioneer Natural Resource Co.
PXD
$2.27M 0.05%
12,609
-201
-2% -$36.8K
RL icon
332
Ralph Lauren
RL
$22.2B
$2.27M 0.05%
25,107
-12,117
-33% -$1.23M
AGEN
333
Agenus
AGEN
$249M
$2.26M 0.05%
27,905
+1,528
+6% +$150K
ALNY icon
334
Alnylam Pharmaceuticals
ALNY
$36.3B
$2.25M 0.05%
60,000
SYY icon
335
Sysco
SYY
$39.7B
$2.23M 0.05%
40,303
-6,616
-14% -$344K
PX
336
DELISTED
Praxair Inc
PX
$2.21M 0.05%
18,902
-3,972
-17% -$472K
SUPN icon
337
Supernus Pharmaceuticals
SUPN
$2.68B
$2.2M 0.05%
+87,000
New +$1.94M
TRP icon
338
TC Energy
TRP
$73.5B
$2.19M 0.05%
48,484
-2,507
-5% -$114K
BN icon
339
Brookfield
BN
$102B
$2.16M 0.05%
183,607
+1,340
+0.7% +$16.3K
KEYS icon
340
Keysight
KEYS
$54.5B
$2.16M 0.05%
+58,980
New +$2.03M
NKTR icon
341
Nektar Therapeutics
NKTR
$2.39B
$2.15M 0.05%
11,667
-1,666
-12% -$339K
PGR icon
342
Progressive
PGR
$124B
$2.14M 0.05%
60,283
+4,145
+7% +$137K
CME icon
343
CME Group
CME
$92.2B
$2.13M 0.05%
18,489
+1,209
+7% +$135K
SPGI icon
344
S&P Global
SPGI
$126B
$2.13M 0.05%
19,793
+2,103
+12% +$251K
ATHM icon
345
Autohome
ATHM
$2.43B
$2.12M 0.05%
+84,000
New +$2.17M
EW icon
346
Edwards Lifesciences
EW
$47.6B
$2.11M 0.05%
67,488
+8,769
+15% +$284K
STZ icon
347
Constellation Brands
STZ
$22.2B
$2.09M 0.05%
13,604
+8,692
+177% +$1.38M
EXC icon
348
Exelon
EXC
$48.6B
$2.08M 0.05%
82,243
+4,530
+6% +$107K
DE icon
349
Deere & Co
DE
$170B
$2.06M 0.05%
19,950
-4,052
-17% -$381K
ZTS icon
350
Zoetis
ZTS
$31.6B
$2.04M 0.05%
38,055
+2,976
+8% +$151K

Similar funds

Candriam SCA's Q4 2016 Portfolio in Review

As of Q4 2016, Candriam SCA held 714 positions worth $4.36B, up 4.8% from $4.16B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA's Q4 2016 filing shows 57 new, 313 increased, 227 reduced and 46 closed positions. Its largest new stake was Coty: 555,452 shares worth $10.2M. The largest sale was Cisco, an estimated $26.2M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Financials and Technology.

  • Candriam SCA's largest Q4 2016 buy was Coty: 555,452 shares worth $10.2M.
  • Candriam SCA added most to Becton Dickinson in Q4 2016, an estimated $27.6M increase.
  • Candriam SCA's biggest Q4 2016 reduction was Cisco, cutting an estimated $26.2M.
  • Candriam SCA fully exited Harman International Industries in Q4 2016, selling an estimated $11.2M.
  • Candriam SCA's ten largest holdings make up 17% of its $4.36B portfolio in Q4 2016.
  • Candriam SCA opened 57 new positions and closed 46 in Q4 2016.
  • Candriam SCA's portfolio value rose 4.8% quarter-over-quarter to $4.36B.

Based on Candriam SCA's 13F filing for Q4 2016, filed 2 Feb 2017.